SEP-0002093
Total Payments
$40,000
Transactions
3
Doctors
1
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2020 | $40,000 | 3 | 1 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Grant | $40,000 | 3 | 100.0% |
Top Doctors Receiving Payments for SEP-0002093
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| , MD | Neurology | Round Rock, TX | $40,000 | 3 |
Ad
Manufacturing Companies
- Sunovion Pharmaceuticals Inc. $40,000
Product Information
- Type Drug
- Total Payments $40,000
- Total Doctors 1
- Transactions 3
About SEP-0002093
SEP-0002093 is a drug associated with $40,000 in payments to 1 healthcare providers, recorded across 3 transactions in the CMS Open Payments database. The primary manufacturer is Sunovion Pharmaceuticals Inc..
Payment data is available from 2020 to 2020. In 2020, $40,000 was paid across 3 transactions to 1 doctors.
The most common payment nature for SEP-0002093 is "Grant" ($40,000, 100.0% of total).